Shilpa Medicare Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 4/6

Shilpa Medicare hat ein Gesamteigenkapital von ₹23.2B und eine Gesamtverschuldung von ₹4.9B, wodurch sich der Verschuldungsgrad auf 21.1% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen ₹31.2B bzw. ₹8.0B. Shilpa Medicare Das EBIT des Unternehmens beträgt ₹1.8B, so dass der Zinsdeckungsgrad 2 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von ₹171.7M.

Wichtige Informationen

21.1%

Verhältnis von Schulden zu Eigenkapital

₹4.89b

Verschuldung

Zinsdeckungsgrad2x
Bargeld₹171.73m
Eigenkapital₹23.19b
Gesamtverbindlichkeiten₹7.98b
Gesamtvermögen₹31.17b

Jüngste Berichte zur Finanzlage

Recent updates

What Shilpa Medicare Limited's (NSE:SHILPAMED) 28% Share Price Gain Is Not Telling You

Sep 12
What Shilpa Medicare Limited's (NSE:SHILPAMED) 28% Share Price Gain Is Not Telling You

Shilpa Medicare Limited's (NSE:SHILPAMED) 29% Price Boost Is Out Of Tune With Revenues

Jul 05
Shilpa Medicare Limited's (NSE:SHILPAMED) 29% Price Boost Is Out Of Tune With Revenues

What Shilpa Medicare Limited's (NSE:SHILPAMED) 27% Share Price Gain Is Not Telling You

Apr 12
What Shilpa Medicare Limited's (NSE:SHILPAMED) 27% Share Price Gain Is Not Telling You

Shilpa Medicare Limited's (NSE:SHILPAMED) Shares Climb 28% But Its Business Is Yet to Catch Up

Feb 21
Shilpa Medicare Limited's (NSE:SHILPAMED) Shares Climb 28% But Its Business Is Yet to Catch Up

Shilpa Medicare (NSE:SHILPAMED) Takes On Some Risk With Its Use Of Debt

Jan 02
Shilpa Medicare (NSE:SHILPAMED) Takes On Some Risk With Its Use Of Debt

These 4 Measures Indicate That Shilpa Medicare (NSE:SHILPAMED) Is Using Debt Extensively

Jul 17
These 4 Measures Indicate That Shilpa Medicare (NSE:SHILPAMED) Is Using Debt Extensively

Shilpa Medicare (NSE:SHILPAMED) Seems To Be Using A Lot Of Debt

Mar 17
Shilpa Medicare (NSE:SHILPAMED) Seems To Be Using A Lot Of Debt

Increases to CEO Compensation Might Be Put On Hold For Now at Shilpa Medicare Limited (NSE:SHILPAMED)

Sep 22
Increases to CEO Compensation Might Be Put On Hold For Now at Shilpa Medicare Limited (NSE:SHILPAMED)

Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10

Sep 07
Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10

Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10

Aug 14
Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10

Here's Why Shilpa Medicare (NSE:SHILPAMED) Is Weighed Down By Its Debt Load

Jan 27
Here's Why Shilpa Medicare (NSE:SHILPAMED) Is Weighed Down By Its Debt Load

Shareholders May Not Be So Generous With Shilpa Medicare Limited's (NSE:SHILPAMED) CEO Compensation And Here's Why

Sep 21
Shareholders May Not Be So Generous With Shilpa Medicare Limited's (NSE:SHILPAMED) CEO Compensation And Here's Why

Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?

Jun 17
Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?

If You Like EPS Growth Then Check Out Shilpa Medicare (NSE:SHILPAMED) Before It's Too Late

May 31
If You Like EPS Growth Then Check Out Shilpa Medicare (NSE:SHILPAMED) Before It's Too Late

Shilpa Medicare Limited's (NSE:SHILPAMED) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Mar 07
Shilpa Medicare Limited's (NSE:SHILPAMED) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Shilpa Medicare Limited (NSE:SHILPAMED) Analysts Are Reducing Their Forecasts For Next Year

Feb 20
Shilpa Medicare Limited (NSE:SHILPAMED) Analysts Are Reducing Their Forecasts For Next Year

Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?

Jan 26
Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: SHILPAMEDDie kurzfristigen Aktiva des Unternehmens (₹8.6B) übersteigen seine kurzfristigen Passiva (₹4.9B).

Langfristige Verbindlichkeiten: SHILPAMEDDie kurzfristigen Vermögenswerte des Unternehmens (₹8.6B) übersteigen seine langfristigen Verbindlichkeiten (₹3.0B).


Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: SHILPAMEDDie Nettoverschuldung im Verhältnis zum Eigenkapital (20.3%) wird als zufriedenstellend angesehen.

Schulden abbauen: SHILPAMEDDas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 18.2% auf 21.1% gestiegen.

Schuldendeckung: SHILPAMEDDie Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (30.7%).

Zinsdeckung: SHILPAMEDDie Zinszahlungen für die Schulden des Unternehmens sind durch das EBIT (2x Deckung) nicht gut gedeckt.


Bilanz


Entdecken Sie finanziell stabile Unternehmen